Filing Details
- Accession Number:
- 0000899243-20-034582
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-12-18 21:32:39
- Reporting Period:
- 2020-12-14
- Accepted Time:
- 2020-12-18 21:32:39
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1501134 | Invitae Corp | NVTA | Services-Medical Laboratories (8071) | 271701898 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1815185 | W. Jason Myers | C/O Invitae Corporation 1400 16Th Street San Francisco CA 94103 | Yes | No | No | Yes |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-12-14 | 171,872 | $0.00 | 1,211,099 | No | 4 | A | Direct | |
| Common Stock | Acquisiton | 2020-12-14 | 152,527 | $0.00 | 1,363,626 | No | 4 | A | Direct | |
| Common Stock | Disposition | 2020-12-16 | 71,869 | $47.32 | 1,291,757 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-12-17 | 12,082 | $46.64 | 1,279,675 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-12-17 | 33,340 | $47.27 | 1,246,335 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-12-17 | 5,270 | $48.23 | 1,241,065 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-12-17 | 300,000 | $0.00 | 941,065 | No | 4 | G | Direct | |
| Common Stock | Disposition | 2020-12-18 | 81,677 | $47.39 | 859,388 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-12-18 | 49,474 | $48.18 | 809,914 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-12-18 | 200 | $48.78 | 809,714 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | A | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | G | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- Received in connection with the achievement of a milestone pursuant to the Agreement and Plan of Merger and Plan of Reorganization, dated as of June 21, 2020, by and among the Issuer, Apollo Merger Sub A Inc., a wholly-owned, direct subsidiary of the Issuer, Apollo Merger Sub B LLC, a wholly-owned, direct subsidiary of the Issuer, ArcherDX, Inc., and Kyle Lefkoff, solely in his capacity as holders' representative.
- Represents the sale of shares to cover tax withholding obligations associated with the issuance of stock.
- The sales of common stock were effected pursuant to a Rule 10b-5 sales plan adopted by the reporting person on October 1, 2020.
- Represents a weighted average sale price. Actual sale prices ranged from $45.91 to $46.90 per share.
- Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated.
- Represents a weighted average sale price. Actual sale prices ranged from $46.91 to $47.90 per share.
- Represents a weighted average sale price. Actual sale prices ranged from $47.94 to $48.90 per share.
- Represents a weighted average sale price. Actual sale prices ranged from $46.74 to $47.73 per share.
- Represents a weighted average sale price. Actual sale prices ranged from $47.74 to $48.73 per share.
- Represents a weighted average sale price. Actual sale prices ranged from $48.74 to $48.81 per share.
Billionaire Hedge Funds
